Tumor 'Mini-Me' could personalize sarcoma therapy
NCT ID NCT07405346
First seen Feb 15, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study tests whether growing a patient's tumor cells in the lab (called organoids) can help doctors choose the most effective first chemotherapy for advanced leiomyosarcoma. About 50 adults with newly diagnosed advanced disease will have their tumor biopsied and tested against multiple drugs. The goal is to see if this personalized approach improves tumor shrinkage and delays cancer growth compared to standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED LEIOMYOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.